Key players in Antifungal Drugs
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 |  Pfizer Inc. |
pfizer.com (opens in a new tab) | 2,310 reports |
| 2 | Astellas Pharma Inc. | — | 264 reports |
| 3 |  Merck & Co., Inc. |
merck.com (opens in a new tab) | 1,320 reports |
| 4 | Mundipharma | — | 33 reports |
| 5 | Basilea Pharmaceutica | — | 33 reports |
Also active in Antifungal Drugs
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
 Sun Pharmaceutical Industries Ltd. |
|
 Aurobindo Pharma |
|
| Padagis US | |
| Zydus Lifesciences | |
| Padagis Israel | |
| Encube | |
| Pharmazone | |
| Macleods Pharmaceuticals | |
| Alembic Therapeutics | |
| Chartwell RX | |
 Hikma Pharmaceuticals PLC |
|
 Amneal Pharmaceuticals, Inc |
Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.
Antifungal Drugs reports by place
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
PhilippinesGet the full Antifungal Drugs report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.